19 drugs have been limited in pharmacies, and provinces may drop more than 100 varieties this year

From now on, 19 drugs have been capped in pharmacies, and provinces may drop more than 100 varieties this year

19 drugs with price limit

On February 17, Shanghai Sunshine Purchasing Network announced the first batch of online purchases of pharmacy-restricted drugs in 2022.

Accompanied by the centralized purchase of drugs into pharmacies, there is also drug price supervision to further cover pharmacies

Shanghai mentioned in the "Notice of the First Batch of Pharmacies Restricted to Online Purchase of Drugs in 2022" that came into effect today (February 17), pharmacies should upload retail prices independently according to the information pushed by the Sunshine platform and the "red and yellow prompt line".

The "red and yellow reminder line" is to make the pharmacies mutually restrict each other by disclosing the pricing of medical insurance pharmacies, so as to achieve the purpose of reducing drug prices

According to the Shenzhen Municipal Medical Insurance Bureau, as long as residents enter the name of the drug in the "Medical Insurance Drug Price Link", they can sort by drug price or pharmacy distance, and update in real time

There are also hundreds of varieties will be reduced in price

The State Council proposed in the "14th Five-Year Plan for National Medical Insurance" that by 2025, more than 500 varieties of national and provincial drugs should be purchased in a centralized manner in each province.

In addition, Shandong, Zhejiang, Shanghai, Guangdong, and Henan have successively included pharmacies into the scope of centralized procurement in the province, which also means that more drugs will be reduced in price in pharmacies in the future.

How does the pharmacy survive?

Li Feng, a special writer for Cyber ​​Blue-pharmacy manager, once said that in the current business situation, a considerable number of chain stores have more than 200 varieties of negative gross profit due to competition and other reasons.

When the prices are similar, the convenience of purchasing medicines in pharmacies will be highlighted.

But realistically speaking, the improvement of micro-profits and passenger flow may not necessarily improve the overall operation of pharmacies.

Although it is good for pharmacies to join the centralized procurement and introduce the centralized procurement drugs, the competition in the professional ability, service level, store location and other aspects of the in-store personnel cannot be achieved by the “one-time effort” of the centralized procurement, especially when all the When all medical insurance pharmacies join the centralized procurement, the advantage brought by the price will be zero again

In general, the price dividends that pharmacies can obtain will become smaller and smaller, and competition will eventually fall to diversified business scopes and professional pharmaceutical services